US 9625473
Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
granted A61KA61K31/785A61K38/02
Quick answer
US patent 9625473 (Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/785, A61K38/02, A61K38/07, A61K9/0019